Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Cerdulatinib |
| Trade Name | |
| Synonyms | PRT062070|PRT2070 |
| Drug Descriptions |
Cerdulatinib (PRT062070) is an ATP-competitive inhibitor of JAK1/3 and SYK, which reduces downstream signaling and may result in decreased tumor growth (PMID: 25253883, PMID: 30333224). |
| DrugClasses | JAK1 Inhibitor - ATP competitive 5 JAK3 Inhibitor - ATP competitive 4 SYK Inhibitor 15 |
| CAS Registry Number | 1198300-79-6 |
| NCIT ID | C113173 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cerdulatinib | Cerdulatinib | 0 | 1 |
| Cerdulatinib + Venetoclax | Cerdulatinib Venetoclax | 0 | 0 |